In a statement shared with CNN, AstraZeneca announced that they will withdraw their successful coronavirus vaccine, Vaxzevria, due to declining demand caused by the availability of multiple new vaccines. The vaccine, developed in partnership with the University of Oxford, has been widely used globally since its first administration in the UK on January 4, 2021. With over 3 billion doses supplied and no revenue generated from the vaccine since April 2023, AstraZeneca has decided to stop manufacturing and supplying the vaccine.
The company has initiated the withdrawal of marketing authorizations for Vaxzevria within Europe as announced by the European Medicines Agency. Despite this decision, AstraZeneca expressed pride in the role that the vaccine played in fighting the global pandemic. The situation is still developing and updates will be provided as needed.
